|Articles|May 6, 2003
Robotically implanted, bioengineered microfistula shows promise as innovation for glaucoma drainage surgery
Ft. Lauderdale-Robotic biological microfistula implantation appears to be a reliable and controllable way to produce a scleral channel between the anterior chamber and subconjunctival space based on animal trials.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Early optogenetic therapy shows promise for patients with inherited retinal diseases
2
Subretinal drusenoid deposits in Black and Hispanic patients with AMD
3
Starting from scratch on neovascular age-related macular degeneration
4
Throwback Series: Identifying and treating neovascular lesions in pregnancy
5